Navigation Links
More Cancer Lymph Nodes Analyzed at Specialty Centers
Date:7/22/2008

If too few are tested, patient's treatment and prognosis may be affected, study says

TUESDAY, July 22 (HealthDay News) -- Patients with stomach or pancreatic cancer may have more lymph nodes examined for the spread of cancer if they're treated at designated comprehensive cancer centers or at hospitals that do a high number of cancer surgeries, says a U.S. study.

If too few lymph nodes are examined for cancer cells, a patient's cancer may be incorrectly classified, altering prognosis, treatment decisions and eligibility for clinical trials, according to background information in the study. Current guidelines for stomach and pancreatic patients recommend examination of at least 15 regional lymph nodes.

The researchers examined National Cancer Data Base records of 3,088 stomach cancer patients and 1,130 pancreatic cancer patients. Of the stomach cancer patients, 11.6 percent had surgery at a hospital designated as a National Cancer Institute (NCI) comprehensive cancer center or as part of the National Comprehensive Cancer Network (NCCN-NCI hospitals), 34 percent had surgery at other academic hospitals (affiliated with a medical school but not designated as NCCN-NCI facilities), and 54.4 percent had surgery at community hospitals.

Of the pancreatic cancer patients, 19 percent had surgery at NCCN-NCI hospitals, 43.3 percent at other academic hospitals, and 37.7 percent at community hospitals.

"Patients undergoing surgery had more lymph nodes examined at NCCN-NCI hospitals than at community hospitals [median [midpoint], 12 vs. six for gastric cancer and nine vs. six for pancreatic cancer]," wrote Dr. Karl Y. Bilimoria, of the American College of Surgeons and Feinberg School of Medicine at Northwestern University in Chicago, and colleagues. "Patients at the highest-volume hospital had more lymph nodes examined than patients at low-volume hospitals [median, 10 vs. six for gastric cancer and eight vs. six for pancreatic cancer]."

Overall, 23.2 percent of stomach cancer patients and 16.4 percent of pancreatic cancer patients had at least 15 lymph nodes evaluated, the study said. Patients at high-volume or NCCN-NCI hospitals were more likely to have at least 15 lymph nodes examined than patients at community or low-volume hospitals.

The study was published in the July issue of the Archives of Surgery.

"Nodal status is a powerful predictor of outcome, and every reasonable attempt should be made to assess the optimal number of lymph nodes to accurately stage disease in patients with gastric [stomach] and pancreatic cancer," the researchers wrote. "Moreover, differences in nodal evaluation may contribute to improved long-term outcomes at NCCN-NCI centers and high-volume hospitals for patients with gastric and pancreatic cancer."

More information

The American Cancer Society has more about stomach cancer.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, July 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Checking more lymph nodes linked to cancer patient survival
2. Has cancer spread? Research identifies best way to find answers so treatment can begin
3. Lung Cancer Trial Targets Asbestos-Related Disease
4. Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
5. Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology
6. New approach to cancer: Find most tightly controlled genes
7. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
8. Weizmann Institute scientists new technique gets to the root of cancer
9. Using magenetic nanoparticles to combat cancer
10. Researchers Find Link Between Organ Transplants, Cancer
11. Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
(Date:3/28/2017)... ... 28, 2017 , ... The Radiology Business Management Association (RBMA) is ... its new executive director. Mr. Still was selected through a careful months-long search by ... he is known to our members, has been a part of building the RBMA ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... Perry, GA (PRWEB) , ... March 28, 2017 , ... ... headquarters to Marshallville, Georgia, in early March. , The seed processing plant opened in ... the location since 2016. The new office allows opportunity for transition of Patten Seed ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... MELVILLE, N.Y. , March 27, 2017 To ... U.S.A. , Inc., a leader in digital imaging ... Vision Expo East convention, held at New York,s ... 2, 2017. Save Your Vision Month, sponsored by the American ... health and the importance of receiving comprehensive eye exams. In ...
(Date:3/27/2017)... 27, 2017  Sophiris Bio Inc. (NASDAQ: ... clinical late-stage biopharmaceutical company developing topsalysin (PRX302) for ... reported fourth quarter and full year 2016 financial ... Key Corporate Highlights: Advanced Topsalysin ... During 2016, the Company reported successful results with ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: